# OnCo record paper-belinda-tisagenlecleucel-second-line-nejm-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-belinda-tisagenlecleucel-second-line-nejm-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-belinda-tisagenlecleucel-second-line-nejm-2022" ;
  schema:name "Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma"@en ;
  schema:alternateName "BELINDA"@en, "Bishop 2022"@en ;
  schema:description "The one second-line CAR-T trial that failed. Its result is best explained by how long the cells took to make and what patients received while they waited."@en ;
  schema:url <https://onco.cc/key-papers/paper-belinda-tisagenlecleucel-second-line-nejm-2022/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2116596>, <https://pubmed.ncbi.nlm.nih.gov/34904798/>, <https://europepmc.org/article/MED/34904798> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2116596> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Bishop MR, Dickinson M, Purtill D, et al." ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/tisagenlecleucel/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:terms <https://onco.cc/terms/bridging-therapy/>, <https://onco.cc/terms/autologous-transplant/>, <https://onco.cc/terms/ipi-score/>, <https://onco.cc/terms/lymphoma-tx-car-t-pathway/> ;
  onco:trials <https://onco.cc/trials/belinda/>, <https://onco.cc/trials/zuma-7/>, <https://onco.cc/trials/transform/>, <https://onco.cc/trials/juliet/> ;
  onco:people <https://onco.cc/people/michael-dickinson/>, <https://onco.cc/people/jason-westin/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-manufacturing-cell-therapy/>, <https://onco.cc/bottlenecks/b-negative-results/>, <https://onco.cc/bottlenecks/b-trial-design/> ;
  onco:journals <https://onco.cc/journals/nejm/> .